International Journal of Risk & Safety in Medicine (IJRSM)
Call for Papers for a Special Issue on Trusted Evidence for Better Health: achievements and barriers
Submit before June 1, 2025
We invite you to submit a manuscript for consideration in a special issue titled, Trusted Evidence for Better Health: Achievements and Barriers. This issue will publish materials from the International Conference "Trusted Evidence for Better Health: achievements and barriers (QiQUM 2025).
QiQUM stands for Quality information for Quality Use of Medicines. It is a tradition of productive collaboration of the Journal and its Publisher with the team of like-minded health professionals, mostly pharmacologists, in Russia, with a history of QiQUM international conferences of 2005, 2010, and 2015, all delivered with support from the Journal and IOS Press.
In 2025, the QiQUM Conference will celebrate 10 years of Cochrane Russia and will publish a special issue celebrating this achievement. The editors hereby call for papers, which could be research articles, short communications, commentaries, case reports, position papers and others. Abstracts are not accepted. See our Submission guidelinesfor further information.
For this issue, the editors will consider manuscripts from any geographic context and across a broad range of health and society topics, professions or scientific disciplines that address the issues of the role of trusted evidence in informed decision-making and health policy in view of new intelligent computer systems, ethical and legal aspects.
These will include, but not will be limited to the role of Cochrane systematic reviews and other products of the Cochrane Collaboration in ensuring quality of health care and development of implementation tools. The editors also specifically invite studies devoted to assessing the impact of misleading information and pervasive conflicts of interest on these processes and products.
Topics include but are not limited to:
- National Essential Medicines lists, the role of evidence
- Clinical Practice Guidelines and promotion of health technologies
- Cochrane evidence in informed decision-making
- Conflicts of interest: their impact on public health, health policy, pharmaceutical policy and management
- Misleading Health Information: Ethics, Norms and Legislation
- Trusted Evidence for Regulatory Decisions in Health, legislation initiatives
- Health Care Quality, the role of Evidence
- Evidence for Health Insurance, Health Economics and Health Policy
- Health systems development based on research evidence
- Evidence Health Literacy and Evidence Education of general public
- Evidence in Health Professional Education
- The role of trusted evidence in Pharmacoepidemiology and Pharmacoeconomics research
- Evidence for Pharmacovigilance
- Evidence-based general Pharmacology and Pharmacy
- Responsibility of health workers across all specialties to deliver evidence-based health care, ethical, normative and legal aspects
- Strategies for curricula adaptation to increase evidence literacy in future generations of health practitioners
- Case examples on these or related topics are welcome
Special Issue Editors
Dmitry Alekseevich Sychev, MD, PhD, DSci (sychevda@rmapo.ru)
Irina Vladimirovna Poddubnaya, MD, PhD, DSci (PoddubnayaIV@rmapo.ru)
Alexandr Leonidovich Khokhlov, MD, PhD, DSci (rector@ysmu.ru)
Ayrat Usmanovich Ziganshin, MD, PhD, DSci (ayrat.ziganshin@kazangmu.ru)
Janne Estill, PhD (chevidence@lzu.edu.cn)
Timeline
March 1, 2025: Special issue open for submissions
July 1, 2025: Manuscript submission deadline
August 1, 2025: Reviews provided to authors
September 1, 2025: Final version deadline
October 1, 2025: Spring/Summer 2026: Publication of the special issue